Ad
related to: moderna stock news update today in the philippines
Search results
Results From The WOW.Com Content Network
There was good news to share, but the market focused on a declining sales forecast and hammered the stock lower. Last November, Moderna said it expected 2024 revenue to land in a range between $3 ...
So, right now, after the stock fell 16% in one trading session on the news, is Moderna a bad-news buy for 2025? Let's find out. An investor works on a laptop at home.
Year to date, Moderna stock has plunged over 60%, with a 52-week low-high of $35.8-$170.47, as per data from Benzinga Pro. ... Moderna unveiled key updates at its annual R&D Day in September ...
But Moderna's news hasn't been as bright recently. Last month, the company revised coronavirus vaccine revenue downward due to lower sales. And in its update this week, the biotech made ...
Moderna's (NASDAQ: MRNA) wild success in the COVID-19 vaccine market has worn off. The company's revenue, earnings, and stock price have been moving in the wrong direction for the past three years ...
Shares of Moderna soared to around 14% on Thursday on the news that a personalized cancer vaccine, produced in partnership with Merck (), reduced the risk of late-stage melanoma by 49%.Moderna has ...
The company's stock was trading slightly up on the news early Monday before falling after market open. Moderna is up almost 20% in the last month after the company received approval from the FDA ...
Science & Tech. Shopping. Sports